Profile data is unavailable for this security.
About the company
SKAN Group AG, former BV Holding AG, is a Switzerland-based holding company of an equity investment group, engaged in the participation in enterprises in Switzerland. It concentrates on companies from the industry, micro and medical technology, processing and material technology, information technology and related services. Target enterprises are those being in special situations, such as management buy-out and buy-in, changes in shareholders’ structure, succession financing, as well as coming through growth or expansion phase. The Company acts as an entrepreneurial partner in the long term. Operational activities are delegated to the independent advisor BV Partners AG. BV Holding AG and BV Partners AG form the BVgroup. As of December 31, 2011, its investment portfolio included nine companies: Covalys BioSciences AG, E2E Technologies Ltd., Lonstroff Holding AG, Piexon AG, POLYDATA AG, SKAN Holding AG, Sphinx Werkzeuge AG, Ypsomed Holding AG and Ziemer Group AG.
- Revenue in CHF (TTM)332.13m
- Net income in CHF16.18m
- Incorporated2001
- Employees1.50k
- LocationSKAN Group AGKreuzstrasse 5ALLSCHWIL 4123SwitzerlandCHE
- Phone+41 432683232
- Fax+41 313801859
- Websitehttps://skan.com/de/home/
Mergers & acquisitions
| Acquired company | SKAN:SWX since announced | Transaction value |
|---|---|---|
| ABC Transfer SAS | -33.46% | -- |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| COLTENE Holding AG | 240.71m | 14.31m | 328.66m | 1.18k | 22.96 | 3.63 | 15.60 | 1.37 | 2.40 | 2.40 | 40.22 | 15.13 | 1.31 | 1.34 | 6.40 | 204,684.50 | 7.80 | 10.59 | 14.26 | 18.43 | 66.11 | 62.19 | 5.95 | 7.64 | 0.7043 | 7.62 | 0.3606 | 85.66 | 3.06 | -1.79 | 71.31 | 0.4306 | -15.45 | 10.76 |
| IVF Hartmann Holding AG | 159.45m | 19.02m | 348.00m | 309.00 | 18.31 | 2.39 | 14.38 | 2.18 | 7.92 | 7.92 | 66.39 | 60.57 | 0.8964 | 3.28 | 7.88 | 526,221.10 | 10.69 | 7.90 | 12.91 | 9.68 | 55.71 | 54.06 | 11.93 | 9.13 | 3.79 | -- | 0.0042 | 48.54 | 7.33 | 2.85 | 34.02 | 10.78 | -28.94 | 19.92 |
| medmix AG | 468.10m | -5.80m | 481.12m | 2.67k | -- | 1.12 | 9.88 | 1.03 | -0.1696 | -0.1696 | 11.60 | 10.39 | 0.4707 | 3.56 | 5.86 | 174,403.90 | -0.4927 | 1.27 | -0.6199 | 1.55 | 34.52 | 35.24 | -1.05 | 2.65 | 1.10 | 1.87 | 0.4268 | 140.79 | -0.5549 | 2.84 | -2,566.67 | -- | 6.02 | -- |
| SKAN Group AG | 332.13m | 16.18m | 1.14bn | 1.50k | 70.47 | 6.43 | 38.20 | 3.43 | 0.7195 | 0.7195 | 14.77 | 7.88 | 0.9052 | 0.709 | 15.33 | 241,201.20 | 4.86 | 7.69 | 9.28 | 16.03 | 74.38 | 72.97 | 5.37 | 8.89 | 0.524 | 16.87 | 0.0518 | 28.09 | 12.90 | 80.51 | 47.47 | 16.66 | -- | -- |
| Medartis Holding AG | 236.34m | -487.00k | 1.19bn | 1.16k | -- | 4.15 | 52.23 | 5.04 | -0.0344 | -0.0344 | 20.25 | 21.03 | 0.5082 | 0.5986 | 5.33 | 249,045.30 | -0.0828 | 0.2609 | -0.0953 | 0.2945 | 79.11 | 81.17 | -0.1629 | 0.4695 | 3.57 | 2.11 | 0.3234 | 0.00 | 6.05 | 11.55 | 469.95 | 10.45 | -10.60 | -- |
| Medacta Group SA | 588.36m | 86.45m | 2.97bn | 2.04k | 34.23 | 7.65 | 19.78 | 5.04 | 4.33 | 4.33 | 29.48 | 19.39 | 0.8113 | 0.853 | 5.83 | 308,527.50 | 11.92 | 9.07 | 15.29 | 11.84 | 67.55 | 69.31 | 14.69 | 11.57 | 0.9472 | 10.51 | 0.3751 | 18.68 | 15.62 | 13.71 | 53.89 | 43.79 | 15.22 | -- |
| Ypsomed Holding AG | 787.55m | 194.00m | 4.12bn | 2.00k | 21.22 | 5.10 | 15.05 | 5.23 | 14.21 | 14.21 | 57.70 | 59.14 | 0.6591 | 6.14 | 5.78 | 297,862.70 | 16.24 | 5.55 | 23.88 | 8.67 | 41.25 | 32.32 | 24.63 | 9.24 | 1.19 | 27.75 | 0.1199 | 19.78 | 36.54 | 13.69 | 11.66 | 49.46 | 18.48 | 61.54 |
| Holder | Shares | % Held |
|---|---|---|
| Z�rcher Kantonalbank (Investment Management)as of 18 Nov 2025 | 1.12m | 4.99% |
| VV Verm�gensverwaltung AGas of 28 Nov 2025 | 690.50k | 3.07% |
| J. Safra Sarasin Investmentfonds AGas of 16 Dec 2025 | 672.26k | 2.99% |
| UBS Asset Management Switzerland AGas of 06 Jan 2026 | 630.55k | 2.81% |
| Vontobel Asset Management AGas of 31 Dec 2025 | 582.82k | 2.59% |
| The Vanguard Group, Inc.as of 07 Jan 2026 | 474.95k | 2.11% |
| Pictet Asset Management SAas of 31 Oct 2025 | 406.96k | 1.81% |
| Norges Bank Investment Managementas of 30 Jun 2025 | 278.32k | 1.24% |
| M&G Investment Management Ltd.as of 31 Dec 2024 | 264.30k | 1.18% |
| SEB Investment Management AB (Denmark)as of 31 Dec 2025 | 219.51k | 0.98% |
